complement
depend
cytotox
cdc
antibodi
depend
cellmedi
cytotox
adcc
make
human
natur
desir
choic
therapeut
antibodi
develop
oncolog
consider
effort
focus
improv
stabil
fc
function
subclass
protein
glycan
engin
twentytwo
fda
approv
therapeut
antibodi
belong
human
human
serum
immunoglobulin
abund
subclass
among
igg
twothird
igg
contain
kappa
light
chain
lc
isotyp
remaind
contain
lambda
lc
wellstudi
structur
provid
rel
stabl
scaffold
well
uniqu
fc
effector
function
optim
biophys
properti
critic
success
factor
develop
monoclon
antibodi
potenti
therapeut
applic
interdomain
disulfid
bond
light
chain
lc
heavi
chain
hc
human
lend
structur
support
antibodi
scaffold
stabil
optim
antigen
bind
normal
fc
function
recent
human
suggest
exhibit
significantli
greater
suscept
reduct
inter
lchc
disulfid
bond
rel
disulfid
bond
human
understand
molecular
basi
observ
differ
stabil
sequenc
structur
human
human
compar
base
lc
comparison
three
singl
mutat
made
lc
proxim
cystein
residu
form
disulfid
bond
hc
determin
delet
ds
improv
resist
associ
lc
hc
thermal
stress
addit
delet
termin
serin
lc
provid
benefit
includ
increas
stabil
elev
ph
increas
yield
transient
transfect
improv
vitro
antibodi
depend
cellmedi
cytotox
adcc
observ
support
conclus
presenc
termin
serin
lc
creat
weaker
interchain
disulfid
bond
lc
hc
lead
slightli
reduc
stabil
potenti
compromis
function
data
human
provid
basi
investig
effect
delet
termin
serin
stabil
function
human
antibodi
remov
ctermin
serin
residu
proxim
interchain
disulfid
bond
human
lambda
light
chain
mediat
enhanc
antibodi
stabil
antibodi
depend
cellmedi
cytotox
focal
environ
cterminu
human
like
affect
stabil
function
destabil
disulfid
bond
lc
hc
studi
report
amino
acid
sequenc
structur
analysi
use
character
molecular
differ
lchc
disulfid
bond
present
human
human
analysi
suggest
three
mutat
residu
proxim
lambda
lc
cystein
particip
interchain
disulfid
bridg
may
contribut
bond
stabil
previous
hc
hing
mutat
human
report
improv
stabil
function
parent
antibodi
moreov
delet
mutat
serin
residu
human
antibodi
demonstr
potenti
increas
disulfid
bond
stabil
upon
partial
reduct
report
effect
delet
termin
serin
ds
lc
stabil
function
select
human
hereaft
refer
examin
extens
ds
variant
profil
enhanc
lchc
disulfid
bond
stabil
heat
elev
ph
increas
transient
express
level
purif
yield
howev
substitut
fail
improv
stabil
parent
interestingli
ds
mutant
demonstr
improv
adcc
activ
well
result
studi
suggest
simpl
engin
approach
increas
stabil
product
fc
function
antibodi
delet
termin
serin
lc
also
confirm
termin
serin
liabil
vicin
cystein
destabil
inter
lchc
disulfid
bond
human
sequenc
structur
ctermini
human
lambda
kappa
light
chain
constant
domain
multipl
line
evid
suggest
lc
isotyp
affect
stabil
function
human
observ
mostli
attribut
suscept
disulfid
bond
link
cl
domain
understand
molecular
differ
isotyp
lc
sequenc
lambda
iii
subfamili
human
lc
gener
hous
select
compar
molecul
contain
lc
constant
region
sequenc
fig
select
lambda
constant
sequenc
blast
pdb
databas
encompass
lambda
ii
iii
subfamili
share
sequenc
ident
amino
acid
level
wherea
share
sequenc
ident
distinct
featur
compar
presenc
serin
residu
immedi
follow
cystein
residu
form
interchain
disulfid
bond
lc
hc
upper
hing
fig
b
contrast
glutam
acid
residu
posit
immedi
cystein
residu
strictli
conserv
across
first
search
perform
look
avail
order
lchc
disulfid
bond
conform
human
xray
crystal
structur
disulfid
bond
analysi
databas
pdb
entri
contain
order
inter
lchc
disulfid
bond
human
select
search
subclass
among
approv
predomin
isotyp
bia
toward
isotyp
like
due
fact
antibodi
chimer
human
deriv
antibodi
gener
mous
ratio
isoform
serum
advent
human
phage
display
librari
contain
balanc
ratio
therapeut
antibodi
isotyp
either
emerg
clinic
pipelin
recent
gain
market
approv
previou
studi
report
howev
slower
assembl
rate
thu
less
stabl
reduc
condit
isotyp
given
recent
trend
develop
lccontain
antibodi
therapeut
import
critic
examin
molecular
basi
observ
instabl
attempt
ration
improv
stabil
function
molecul
class
revers
natur
disulfid
bond
support
pivot
role
maintain
structur
integr
function
protein
includ
igg
although
disulfid
bond
coval
linkag
dissoci
energi
kcalmol
protein
structur
consid
rel
weak
link
molecul
architectur
weaker
carboncarbon
bond
dissoci
energi
kcalmol
recent
find
shown
disulfid
bond
igg
revers
previous
believ
lc
natur
occur
igg
iga
form
disulfid
bond
heavi
chain
hc
also
selfassoci
therebi
creat
lc
dimer
moreov
interhc
disulfid
bond
subclass
requisit
high
disulfid
exchang
rate
observ
enabl
transfer
half
antibodi
hl
two
antibodi
distinct
specif
format
antibodi
dual
specif
natur
addit
disulfid
bond
reshuffl
report
occur
among
differ
pair
cystein
antibodi
lc
hc
two
hc
lead
multipl
disulfidebond
isoform
molecul
detect
capillari
electrophoresi
effect
signific
molecular
heterogen
antibodi
isoform
effect
howev
context
depend
instabl
disulfid
bond
hc
observ
isoform
unpair
cystein
recombin
monoclon
antibodi
may
result
disulfid
bond
instabl
could
affect
develop
molecul
form
coval
link
aggreg
among
igg
subclass
uniqu
interchain
disulfid
bond
pattern
bridg
end
lc
nterminu
hing
region
hc
rather
begin
domain
observ
igg
isoform
lc
hc
disulfid
bond
also
shown
prone
lc
loss
due
degre
disulfid
bond
revers
recent
report
also
shown
disulfid
bond
lc
hc
human
weaker
disulfid
bond
present
two
hc
monitor
reduct
differenti
alkyl
lcm
analysi
importantli
disulfid
bond
lc
hc
human
suscept
breakag
reduc
condit
human
analysi
reveal
serin
residu
cterminu
human
make
signific
contribut
suscept
disulfid
bond
reduct
altogeth
data
impli
due
limit
number
antibodi
entri
pdb
larg
flexibl
tail
lc
search
return
one
entri
lambda
subfamili
complet
order
lchc
disulfid
bond
tabl
fab
structur
pdb
becom
disord
ctermin
region
near
cystein
lc
sequenc
comparison
share
high
sequenc
ident
lc
test
antibodi
ident
lc
ident
fig
therefor
use
repres
limit
cystein
residu
number
lc
hc
sinc
uniqu
lchc
disulfid
bond
pattern
differ
cystein
locat
hc
also
exclud
discuss
residu
number
criterion
avoid
inaccuraci
coordin
crystal
structur
resolut
higher
select
complet
analysi
multipl
structur
desir
first
step
understand
whether
common
structur
featur
around
lchc
disulfid
bond
howev
equival
lc
calcul
compar
fig
tabl
due
lack
multipl
entri
averag
per
residu
b
factor
directli
compar
overal
averag
per
residu
b
factor
equival
locat
avail
structur
cystein
locat
averag
b
factor
contrast
overal
averag
b
factor
likewis
averag
b
factor
conserv
glutam
acid
residu
higher
observ
limit
sampl
elev
b
factor
indic
flexibl
natur
atom
near
lchc
disulfid
bond
destabil
environ
disulfid
bond
possibl
select
antibodi
discuss
dihedr
strain
energi
bond
distanc
lchc
disulfid
bond
human
structur
order
lchc
disulfid
bond
pdb
analyz
dihedr
strain
energi
approxim
use
measur
destabil
effect
given
disulfid
surprisingli
lchc
interchain
disulfid
bond
higher
dihedr
strain
energi
structur
test
antibodi
compar
although
conclus
structur
analysi
could
gener
due
lack
multipl
exampl
complet
lchc
disulfid
bond
structur
featur
believ
serv
represent
select
antibodi
discuss
given
high
sequenc
ident
fig
understand
rel
stabil
lchc
disulfid
bond
flexibl
lc
termin
cystein
equival
pdb
glutam
acid
equival
pdb
lchc
disulfid
bond
databas
analyz
compar
b
factor
describ
mean
squar
displac
atom
two
locat
crystal
structur
disulfid
bond
databas
structur
within
domain
b
factor
atom
cystein
ctermini
higher
residu
locat
prior
c
termini
differ
highlight
flexibl
natur
protein
region
surround
disulfid
bond
lc
hc
averag
b
factor
cystein
residu
equival
involv
lchc
disulfid
bond
adjac
conserv
glutam
acid
residu
contain
lc
potenti
less
stabl
interchain
disulfid
bond
fab
lc
first
point
toward
form
disulfid
bond
h
wherea
posit
main
chain
make
degre
turn
away
h
fig
accommod
extra
serin
residu
avoid
steric
interfer
domain
fig
addit
strength
lambda
lchc
disulfid
bond
could
also
neg
affect
interact
trail
serin
residu
given
high
flexibl
end
amid
group
could
form
hydrogen
bond
therebi
weaken
disulfid
bond
neg
charg
carboxyl
group
cterminu
lc
could
initi
nucleophil
attack
potenti
weaken
disulfid
bond
lc
hc
interestingli
hydroxyl
side
chain
termin
serin
orient
opposit
side
disulfid
bond
make
less
like
side
chain
function
group
involv
destabil
consist
observ
serin
alanin
mutat
end
lc
reduc
interchain
disulfid
bond
suscept
reduct
taken
togeth
data
afford
databas
structur
comparison
reveal
lchc
disulfid
bond
avail
structur
potenti
select
antibodi
report
herein
inher
less
stabl
main
chain
conform
termin
serin
end
constant
region
select
antibodi
could
neg
effect
stabil
disulfid
link
lc
hc
delet
ctermin
serin
improv
thermal
stabil
disulfid
bond
lc
hc
analysi
amino
acid
sequenc
structur
suggest
might
less
stabl
disulfid
bond
lc
hc
instabl
could
neg
affect
develop
class
therapeut
kjmol
contrast
averag
kjmol
interchain
disulfid
bond
avail
human
antibodi
structur
tabl
moreov
bond
distanc
two
atom
pair
cystein
markedli
deviat
averag
distanc
atom
human
antibodi
structur
tabl
next
rotam
analysi
perform
program
coot
compar
sidechain
torsion
angl
lchc
disulfid
form
cystein
antibodi
databas
tabl
rotam
databas
coot
cystein
residu
report
pdb
follow
distribut
cystein
distribut
anoth
deviat
lc
termin
cystein
angl
antibodi
closest
rotam
databas
calcul
tabl
averag
avail
lchc
cystein
rang
howev
lchc
cystein
deviat
significantli
closest
rotam
tabl
suggest
nonoptim
align
sulfur
atom
lchc
disulfid
bond
contribut
consist
less
ideal
lchc
disulfid
profil
indic
previou
analys
b
factor
strain
energi
bond
distanc
gain
insight
contribut
addit
termin
serin
residu
lchc
disulfid
bond
crystal
structur
pdb
ident
test
antibodi
superimpos
select
pdb
refer
comparison
domain
fab
superimpos
ident
fig
rmsd
atom
across
align
residu
domain
overal
conform
around
cystein
residu
ctermini
found
differ
sever
observ
indic
disulfid
bond
lc
hc
fab
pdb
entri
obtain
disulfid
bond
databas
analysi
tabl
angl
calcul
perform
use
rotam
databas
program
coot
defin
disulfid
bond
stabil
differ
molecular
level
singl
point
mutat
made
around
cystein
residu
cterminu
lc
constant
region
three
mutant
introduc
residu
found
lc
creat
sitedirect
mutagenesi
delet
locat
select
residu
base
lack
sequenc
ident
posit
across
multipl
sequenc
align
fig
b
ensur
variant
retain
biolog
function
bind
target
receptor
x
test
antigen
elisa
compar
ec
nm
mutant
similar
ec
receptor
x
bind
rang
nm
indic
alter
bind
properti
aros
result
direct
mutat
lc
constant
region
tabl
thermal
stabil
nativ
mutant
evalu
pattern
lc
hc
associ
determin
rt
compar
nativ
fig
intact
igg
ratio
defin
stain
intens
lhhl
rel
stain
intens
speci
also
determin
antibodi
differ
temperatur
fig
display
markedli
improv
associ
lc
hc
base
reduc
level
hh
kd
h
kd
speci
fig
increas
amount
lhhl
fig
mutat
enhanc
stabil
disulfid
bond
lc
hc
level
partial
igg
speci
temperatur
confirm
higher
suscept
breakag
interchain
disulfid
bond
thermal
challeng
assay
use
acceler
process
order
monitor
differ
associ
hc
lc
antibodi
incub
variou
temperatur
min
resolv
sdspage
nonreduc
condit
first
compar
associ
lc
hc
inhous
antibodi
inhous
antibodi
room
temperatur
fig
room
temperatur
antibodi
remain
larg
intact
primari
speci
migrat
molecular
weight
kd
lhhl
fig
antibodi
becam
dissoci
evidenc
appear
sever
band
lower
molecular
weight
intens
band
pattern
visibl
greater
lc
antibodi
lc
antibodi
primari
band
migrat
kd
suggest
loss
one
hhl
two
lc
hh
fig
interestingli
minim
amount
speci
kd
hl
observ
impli
lchc
disulfid
bond
hchc
disulfid
bond
neg
affect
lc
contrast
temperatur
show
moder
loss
two
lc
result
band
much
weaker
intens
kd
hh
percentag
intact
determin
wherea
fig
addit
aforement
antibodi
antibodi
also
test
thermal
challeng
assay
similar
differ
observ
see
discuss
disulfid
bond
breakag
strike
differ
stabil
seen
ph
fig
major
antibodi
similar
level
nativ
fig
intact
igg
ratio
decreas
much
slower
rate
increas
temperatur
rel
nativ
result
remain
intact
similar
control
antibodi
fig
e
contrast
intact
igg
remain
nativ
condit
surprisingli
singl
serin
delet
c
terminu
lc
led
stabl
lchc
disulfid
bond
sinc
mutat
prior
cystein
demonstr
improv
stabil
lchc
disulfid
ds
mutant
test
follow
studi
investig
whether
improv
thermal
stabil
lchc
disulfid
bond
could
confer
thermal
stabl
fab
igg
thermal
melt
profil
determin
use
differenti
scan
calorimetri
dsc
fig
littl
differ
observ
melt
temperatur
fab
domain
therefor
correl
improv
lchc
disulfid
bond
overal
thermal
stabil
fab
igg
test
molecul
delet
ctermin
serin
lc
enhanc
lchc
disulfid
bond
stabil
high
ph
explor
benefit
improv
coval
associ
lc
hc
serin
delet
mutant
disulfid
bond
stabil
antibodi
nativ
serin
delet
mutant
examin
basic
neutral
acid
condit
incub
buffer
contain
mm
iodoacetamid
ph
ph
ph
antibodi
separ
nonreduc
sdspage
dissoci
lc
hc
assess
lchc
disulfid
bond
three
antibodi
show
indistinguish
stabil
acid
ph
minor
sign
dissoci
lc
thermal
stress
loss
lc
becam
appar
neutral
ph
experiment
condit
fig
ph
serin
delet
mutant
stabl
kappa
lc
wherea
lambda
lc
show
loss
lc
indic
greater
suscept
lchc
fig
suggest
delet
termin
serin
render
disulfid
bond
resist
breakag
higher
ph
higher
suscept
lchc
disulfid
bond
break
basic
ph
like
associ
combin
greater
reduct
potenti
high
ph
buffer
less
reduct
potenti
weaker
disulfid
bond
reduc
invers
relationship
ph
redox
potenti
nomin
mvph
unit
therefor
increas
ph
also
lower
solut
potenti
render
reduc
environ
rel
lower
ph
moreov
remov
termin
serin
lchc
disulfid
becom
stronger
bond
therefor
resist
reduc
basic
ph
compar
bond
conclus
hypothes
chang
potenti
result
increas
ph
suffici
effect
differ
revers
lchc
disulfid
bond
test
improv
express
purif
serin
delet
mutant
explor
consequ
stabil
interchain
disulfid
bond
delet
ctermin
serin
residu
cterminu
lc
express
level
behavior
purif
engin
antibodi
examin
hek
cell
transient
transfect
separ
express
level
antibodi
quantifi
use
octet
biosensor
fortebio
transient
express
significantli
higher
mgl
vs
mgl
p
fig
process
yield
evalu
affin
chromatographi
protein
column
procedur
use
routin
captur
igg
remov
impur
process
analysi
done
elut
condit
ph
precipit
observ
either
elut
column
subsequ
hold
step
low
ph
elut
column
ph
process
yield
high
contrast
load
protein
column
elut
condit
elut
pool
neutral
ph
use
solut
tri
base
precipit
occur
similar
extent
base
turbid
solut
high
recoveri
clarif
step
follow
neutral
howev
indic
precipit
due
host
cell
protein
impur
antibodi
find
demonstr
improv
transient
express
perform
purif
engin
serin
delet
mutant
enhanc
express
purif
process
mutant
like
attribut
better
assembl
ds
lc
hc
igg
produc
delet
ctermin
serin
enhanc
adcc
activ
mutat
hing
region
report
amelior
cdc
adcc
introduct
disulfid
bond
lc
hc
complet
abrog
adcc
activ
underlin
import
interact
fc
effector
function
interchain
lost
lc
domin
speci
hh
kd
fig
moder
amount
hhl
form
also
present
indic
loss
one
lc
fig
minim
amount
remain
intact
igg
contrast
lc
remain
stabli
attach
hc
fig
moder
loss
lc
hh
speci
compar
high
ph
stabl
stabl
serin
delet
significantli
improv
associ
lc
hc
stabil
interchain
disulfid
linkag
signific
amount
mutant
still
remain
intact
igg
lc
fig
moreov
serin
delet
mutant
show
higher
amount
igg
one
miss
lc
hhl
lower
amount
igg
two
miss
lc
hh
compar
variou
perform
surpris
differ
bind
affin
comparison
data
shown
sinc
assess
solid
surfac
may
repres
scenario
antibodi
abl
bind
target
effector
target
cell
happen
cell
base
adcc
assay
see
detail
discuss
evalu
antibodymedi
effector
cell
activ
presenc
target
cell
confirm
improv
adcc
engin
report
jurkat
cell
stabli
overexpress
receptor
high
affin
variant
use
effector
induc
increas
background
effector
cell
activ
satur
concentr
compar
increas
fig
data
good
agreement
observ
adcc
assay
corrobor
robust
adcc
activ
taken
togeth
adcc
effector
cell
activ
studi
clearli
support
connect
stabl
lchc
disulfid
bond
delet
trail
serin
residu
better
adcc
activ
particular
antibodi
pharmacokinet
comparison
serin
delet
mutant
nativ
given
serin
delet
lc
result
improv
adcc
activ
suggest
modul
structur
function
properti
disulfid
bond
lc
hc
situat
upper
hing
region
henc
possibl
stabil
hing
region
disulfid
lc
hc
may
indirectli
alter
effector
function
stabil
conform
effect
hing
region
thermal
challeng
ph
stabil
studi
present
indic
delet
ctermin
serin
lc
strengthen
coval
interact
lc
hc
hing
region
fig
assess
effect
serin
delet
effector
function
adcc
activ
evalu
treat
cell
overexpress
target
receptor
x
antibodi
presenc
pbmc
effector
cell
fig
b
effector
target
cell
ratio
e
nativ
antibodi
modest
adcc
cell
show
lysi
wherea
induc
lysi
cell
fig
also
display
greater
potenc
ec
nm
compar
nm
fig
consist
e
demonstr
superior
adcc
activ
nativ
kill
cell
vs
fig
ec
improv
fourfold
nm
rel
ec
nm
demonstr
fig
summari
two
differ
e
ratio
demonstr
greater
adcc
activ
confirm
whether
observ
enhanc
adcc
activ
improv
bind
elisa
bind
amino
acid
respons
observ
destabil
hypothesi
support
analysi
two
mutat
cterminu
lc
previou
studi
partial
reduct
differenti
alkyl
c
c
iodoacet
acid
disulfid
bond
lc
hc
reduc
free
cystein
nativ
termin
serin
variant
termin
alanin
contrast
disulfid
bond
lc
hc
reduc
free
cystein
variant
termin
serin
residu
delet
lack
resist
reduct
alanin
mutant
like
alanin
preserv
characterist
serin
mainchain
backbon
previou
report
point
liabil
termin
serin
stabil
focus
character
differ
among
lc
mutant
suscept
chemic
reduct
current
report
encompass
sequenc
structur
stabil
function
character
provid
insight
molecular
basi
differ
select
ds
stabil
function
also
provid
first
complet
analysi
effect
termin
serin
properti
human
investig
effect
termin
serin
end
lc
two
doubl
mutant
construct
evalu
thermal
stabil
respons
doubl
mutant
thermal
stress
ident
observ
data
shown
support
find
termin
serin
primari
residu
vicin
interchain
disulfid
bond
lc
hc
human
contribut
lower
stabil
rel
interestingli
major
intermedi
speci
produc
human
thermal
ph
stress
hh
dimer
suggest
serin
residu
introduc
greater
suscept
disulfid
bond
lc
hc
condit
good
agreement
previou
studi
expect
addit
serin
residu
mutat
end
human
would
produc
less
stabl
lchc
disulfid
bond
similar
observ
support
recent
find
variou
build
block
includ
scfv
singl
domain
protein
scaffold
peptid
link
c
terminu
cl
igg
construct
mutispecif
antibodi
consist
observ
other
extra
serin
weaken
lchc
disulfid
bond
addit
extra
amino
acid
scfv
peptid
follow
last
cystein
human
destabil
lchc
disulfid
bond
lead
increas
partial
assembl
igg
fusion
molecul
hhl
hh
compar
nativ
igg
molecul
western
blot
analysi
case
disrupt
natur
occur
lchc
disulfid
bond
appear
affect
bind
serum
stabil
stabil
low
ph
howev
effect
loss
coval
linkag
lc
hc
function
might
vari
molecul
molecul
therefor
care
examin
stabil
function
advis
construct
multispecif
molecul
addit
c
terminu
lc
confirm
whether
delet
ctermin
serin
could
serv
gener
engin
approach
strengthen
lchc
fc
domain
interest
determin
whether
mutat
may
also
affect
vivo
pharmacokinet
pk
properti
compar
vivo
stabil
serin
delet
mutant
parent
pk
profil
obtain
mice
administr
singl
dose
intraperiton
mgkg
antibodi
plasma
concentr
determin
time
pk
paramet
deriv
good
agreement
deriv
parent
fig
halflif
compar
valu
obtain
total
exposur
auc
h
h
data
suggest
stabil
disulfid
bond
lc
hc
delet
serin
residu
cterminu
lc
affect
pk
select
interchain
disulfid
bond
lc
hc
critic
coval
associ
support
structur
igg
shown
previous
disulfid
linkag
lc
hc
human
suscept
reduct
disulfid
bond
two
hc
lc
hc
human
analys
data
deriv
disulfid
bond
databas
structur
comparison
measur
stabil
process
function
present
support
find
earlier
studi
provid
addit
mechanist
insight
natur
less
stabl
interact
lc
hc
select
human
antibodi
delet
addit
serin
residu
follow
penultim
cystein
cterminu
lc
improv
thermal
stabil
stabil
high
ph
transient
express
purif
yield
adcc
function
antibodi
examin
studi
possibl
side
chain
termin
serin
residu
could
introduc
steric
hindranc
destabil
disulfid
bond
lc
hc
structur
comparison
lc
suggest
featur
backbon
activ
jurkat
cell
parent
antibodi
upon
bind
target
cell
addit
unlik
hing
stabil
mutant
stabl
disulfid
bond
lc
hc
due
delet
termin
lc
residu
like
indirect
effect
stabil
hing
less
effect
bind
conclus
studi
need
detail
mechan
adcc
enhanc
result
delet
ctermin
serin
order
determin
whether
effect
gener
antibodi
known
interact
fcrn
crucial
maintain
circul
concentr
vivo
major
residu
involv
fcrn
bind
locat
close
proxim
junction
domain
away
hing
region
interchain
disulfid
bond
lc
hc
therefor
molecular
chang
around
hing
region
less
like
alter
pk
properti
antibodi
ds
mutant
improv
pk
properti
consist
data
show
hc
hing
mutat
also
alter
pk
properti
human
igg
moreov
report
previous
pk
profil
remain
entir
switch
human
advanc
antibodi
display
librari
human
antibodi
lc
isotyp
identifi
preclin
program
enter
clinic
pipelin
inferior
stabil
disulfid
bond
lc
hc
could
potenti
hinder
success
develop
human
antibodi
class
effect
therapeut
agent
studi
present
focus
region
around
disulfid
bond
lc
hc
provid
extens
character
stabil
function
human
antibodi
suggest
critic
role
ctermin
serin
residu
lc
stabil
lchc
interact
human
importantli
demonstr
delet
serin
enhanc
stabil
express
process
adcc
activ
without
affect
bind
antigen
examin
properti
specif
pair
antibodi
might
repres
uniqu
case
analysi
present
report
serv
gener
framework
test
antibodi
human
isotyp
investig
larg
number
human
confirm
whether
delet
ctermin
serin
gener
platform
improv
properti
human
reduc
time
cost
develop
class
molecul
therapeut
use
sequenc
databas
structur
analysi
lambda
lc
constant
domain
sequenc
select
inhous
human
lambda
hereaft
refer
antibodi
use
blast
databas
search
pdb
pdb
access
id
sequenc
contain
select
repres
kappa
lc
constant
domain
sequenc
pdb
pdb
chosen
directli
pdb
databas
sequenc
align
compar
use
clustal
w
server
disulfid
bond
ds
mutat
incorpor
anoth
antibodi
distinct
vl
vh
domain
preliminari
data
test
stabil
temperatur
ph
demonstr
clearli
similar
improv
ds
molecul
rel
nativ
unpublish
data
data
addit
suggest
enhanc
stabil
lchc
disulfid
bond
delet
trail
serin
residu
might
generaliz
moreov
although
differ
stabil
antibodi
report
could
origin
sequenc
differ
vlvh
pair
recent
data
use
two
variat
region
confirm
variat
suffici
induc
less
stabl
lchc
disulfid
bond
high
ph
unpublish
data
valid
neg
effect
termin
serin
stabil
disulfid
bond
conserv
littl
influenc
variabl
region
observ
enhanc
transient
express
yield
result
serin
delet
may
outcom
effici
secret
whole
igg
known
lc
displac
chaperon
bip
associ
hc
endoplasm
reticulum
er
form
final
lhhl
complex
allow
secret
intact
antibodi
sinc
nativ
lc
weaker
disulfid
bond
interact
lc
hc
compar
lc
serin
delet
unassembl
nativ
lc
retain
er
form
coval
complex
microsom
protein
ds
mutant
hypothes
base
studi
better
associ
lc
hc
improv
disulfid
bond
interact
assembl
process
er
may
lead
properli
assembl
lhhl
complex
higher
secret
level
one
initi
consider
note
increas
adcc
activ
observ
ds
mutant
increas
antibodi
bind
recent
report
mutat
upper
hing
hc
human
antibodi
improv
stabil
adcc
function
prevent
cleavag
hchc
disulfid
bond
radicalinduc
degrad
enhanc
adcc
activ
correl
higher
affin
unlik
mutant
show
improv
bind
elisa
compar
nativ
igg
data
shown
nevertheless
serin
delet
mutant
demonstr
enhanc
adcc
activ
improv
adcc
activ
result
delet
termin
serin
interest
unexpect
suggest
increas
adcc
activ
result
serin
delet
lc
oper
mechan
differ
mutat
upper
hing
region
hc
discrep
result
bind
adcc
assay
studi
might
due
differ
assay
format
hypothes
conform
chang
hing
region
induc
delet
serin
could
affect
bind
site
upon
bind
cell
surfac
antigen
cell
surfac
occur
adcc
assay
elisa
bind
assay
hypothesi
partial
corrobor
effector
cell
activ
data
induc
greater
increas
dnafectin
complex
incub
antibodi
express
level
cultur
supernat
determin
use
octet
protein
biosensor
pall
octet
harvest
cell
cultur
supernat
contain
recombin
igg
igg
load
onto
mabselect
sure
protein
ge
health
care
preequilibr
phosphatebuff
salin
pb
invitrogen
ph
column
bed
volum
ml
oper
graviti
flow
antibodi
elut
use
mm
citrat
buffer
ph
ph
protein
elut
pool
held
room
temperatur
one
hour
final
elut
pool
neutral
ph
tri
base
solut
antibodi
concentr
partial
purifi
solut
determin
absorb
nm
use
nanodrop
system
thermo
scientif
thermal
challeng
assay
fifteen
prepar
pb
nupag
ld
sampl
buffer
invitrogen
total
volum
ul
mixtur
incub
min
differ
temperatur
room
temperatur
rt
use
thermocycl
eppendorf
treat
sampl
load
onto
nupag
gel
invitrogen
subject
electrophoresi
v
h
gel
stain
simplyblu
safestain
invitrogen
scan
use
alpha
imag
proteinsimpl
estim
intact
igg
ratio
nativ
differ
temperatur
densitometr
analysi
perform
band
band
repres
fulli
assembl
igg
lhhl
quantifi
subtract
background
densiti
lane
use
photoshop
adob
intact
igg
ratio
intens
lhhl
intens
band
calcul
plot
vs
temperatur
higher
intact
igg
ratio
temperatur
correspond
increas
thermal
stabil
interchain
disulfid
bond
specif
mutant
ph
stabil
assay
antibodi
sampl
mgml
prepar
mix
antibodi
human
human
antibodi
mgml
sampl
buffer
contain
mm
buffer
solut
sodium
acet
ph
sodium
phosphat
ph
sodium
phosphat
ph
sd
mm
iodoacetamid
iam
acet
acid
sodium
acet
trihydr
disodium
hydrogen
phosphat
hcl
iam
purchas
sigmaaldrich
antibodi
sampl
incub
min
vari
ph
held
min
treat
sampl
separ
nupag
gel
invitrogen
gel
stain
simplyblu
safestain
invitrogen
scan
alpha
imag
proteinsimpl
adcc
assay
cytotox
detect
kit
roch
use
character
adcc
activ
releas
lactat
dehydrogenas
ldh
activ
lyse
target
cell
transfect
receptor
target
x
monitor
presenc
freshli
isol
normal
peripher
blood
mononuclear
cell
pbmc
allcel
upon
treatment
antibodi
cell
seed
well
roundbottom
plate
assay
medium
contain
rpmi
bsa
unitsml
databas
search
perform
obtain
complet
list
order
lchc
disulfid
bond
structur
paramet
human
xray
crystal
structur
disulfid
bond
analysi
databas
curat
detail
structur
inform
disulfid
bond
protein
structur
pdb
gener
restrict
lchc
disulfid
bond
subset
databas
human
follow
criteria
appli
disulfid
bond
analysi
databas
restrict
select
immun
system
header
column
limit
resolut
better
remov
entri
contain
lc
dimer
select
disulfid
bond
residu
number
cystein
advantag
subset
origin
disulfid
bond
analysi
databas
pdb
entri
select
complet
lchc
disulfid
bond
alreadi
comparison
search
directli
pdb
final
lchc
disulfid
bond
databas
contain
fab
sequenc
fab
sequenc
disulfid
bond
strain
energi
bond
distanc
obtain
directli
disulfid
bond
analysi
databas
averag
b
factor
per
residu
cystein
equival
pdb
glutam
acid
equival
cl
calcul
comparison
torsion
angl
everi
cystein
involv
interchain
disulfid
bond
calcul
use
program
coot
deviat
cystein
closest
report
rotam
databas
coot
also
calcul
compar
crystal
structur
pdb
select
repres
structur
inhous
antibodi
given
high
sequenc
ident
pdb
select
refer
molecul
comparison
select
entri
superimpos
within
domain
use
dalilit
illustr
cartoon
stick
represent
use
program
pymol
sitedirect
mutagenesi
elisa
gener
quickchang
lightn
sitedirect
mutagenesi
kit
agil
follow
manufactur
manual
use
construct
templat
elisa
plate
immulon
thermoscientif
coat
recombin
solubl
antigen
x
pb
overnight
block
pbst
pb
buffer
nonfat
milk
room
temperatur
h
plate
wash
three
time
pbst
serial
dilut
antibodi
pb
ad
block
elisa
plate
incub
room
temperatur
h
follow
three
wash
pbst
plate
incub
room
temperatur
h
block
buffer
contain
goat
antihuman
f
ab
igghorseradish
peroxidas
conjug
jackson
immunoresearch
wash
plate
develop
use
tmb
peroxidas
substrat
kpl
read
absorb
nm
analysi
express
purif
human
embryon
kidney
hek
cell
invitrogen
cultiv
transfect
accord
manufactur
instruct
suspens
shake
flask
cultur
briefli
uncut
plasmid
dna
harbor
igg
igg
express
construct
mix
fectin
allow
complex
min
hek
cell
resuspend
fresh
medium
combin
cell
activ
maxim
rlubackground
rlu
data
analyz
use
graphpad
prism
graphpad
softwar
inc
vivo
pk
studi
femal
mice
age
week
obtain
charl
river
laboratori
mice
hous
pathogenfre
condit
microisol
cage
laboratori
chow
water
avail
ad
libitum
anim
research
method
approv
institut
anim
care
use
committe
perform
accord
unit
state
depart
agricultur
nation
institut
health
polici
regard
human
care
use
laboratori
anim
one
week
acclimat
mice
random
group
inject
mgkg
transient
express
purifi
igg
igg
intraperiton
ip
three
mice
bled
prior
dose
establish
plasma
level
three
mice
per
timepoint
bled
plasma
h
dose
group
edta
plasma
sampl
collect
store
concentr
evalu
standard
antihuman
fc
bind
elisa
briefli
immunlon
plate
vwr
coat
goat
antihuman
fc
igg
sigma
serial
dilut
igg
standard
plasma
sampl
incub
coat
plate
follow
detect
horseradish
peroxidas
conjug
goat
anti
human
fc
igg
jackson
immunoresearch
pk
paramet
calcul
util
noncompartment
analysi
winnonlin
softwar
pharsight
pk
paramet
calcul
base
h
time
point
group
potenti
conflict
interest
disclos
supplement
materi
may
found
http
penicillin
streptomycin
serial
dilut
antibodi
start
nm
nm
ad
plate
contain
target
cell
follow
incub
min
effector
pbmc
cell
ad
plate
effector
target
cell
e
ratio
incub
antibodi
target
cell
co
h
plate
centrifug
end
incub
well
supernat
test
ldh
activ
briefli
ldh
reaction
mixtur
ad
supernat
plate
incub
room
temperatur
min
constant
shake
reaction
stop
hcl
absorb
measur
nm
nm
background
subtract
well
use
spectramax
plu
micropl
reader
molecular
devic
absorb
well
contain
target
cell
lyse
defin
high
control
absorb
well
contain
target
cell
consid
low
control
antibodyindepend
cellular
cytotox
aicc
measur
condit
target
effector
cell
alon
absenc
antibodi
specif
adcc
percentag
cell
lysi
calcul
follow
equat
cell
lysi
sampl
aicc
high
control
low
control
data
plot
analyz
use
graphpad
prism
graphpad
softwar
inc
effector
cell
activ
assay
cell
wash
pb
seed
flatbottom
plate
assay
buffer
bsa
rpmi
plate
incub
humidifi
incub
co
overnight
cultur
effector
cell
promega
collect
spun
plate
flask
assay
buffer
overnight
next
day
igg
nm
start
concentr
dilut
ratio
ad
plate
contain
cell
mixtur
antibodi
target
cell
incub
min
ice
allow
bind
effector
cell
collect
wash
three
time
pb
ad
plate
e
ratio
follow
incub
incub
plate
remov
left
room
temperatur
equilibr
min
bright
glo
luciferas
reagent
promega
ad
luminesc
record
luminomet
perkin
elmer
fold
increas
effector
